ATLAS VENTURE ASSOCIATES X, L.P.
CIK 1742766 · last filed 2024-03-13
ATLAS VENTURE ASSOCIATES X, L.P. is a corporate insider who has filed 12 SEC Form 4 insider transactions across 6 companies since 2018. The most recent filing shows the insider sold $14.9M of KYMR on Mar 13, 2024. Across all open-market trades the lifetime net is −$87.3M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $918.4M across reported positions. The firm reports its address in Cambridge, MA. 38 SEC filings were submitted jointly with Atlas Venture Associates X, LLC.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
KYMR price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
10TH FLOOR
CAMBRIDGE, MA 02139
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| KYMR | 10%+ Owner | 5,504,905 | $119.44 | $657.53M | -$49.24M | 5 | 2024-03-13 |
| IRON | 10%+ Owner | 2,285,846 | $76.35 | $174.52M | -$30.53M | 2 | 2023-12-14 |
| Generation Bio Co. (GBIO) Delisted | 10%+ Owner | 911,194 | $5.34 | $4.87M | -$7.23M | 2 | 2021-04-14 |
| Tectonic Therapeutic, Inc. (AVRO) Delisted | 10%+ Owner | 309,171 | $16.80 | $5.19M | $0 | 1 | 2020-02-18 |
| Dianthus Therapeutics, Inc. /DE/ (MGTA) Delisted | 10%+ Owner | 258,210 | $11.19 | $2.89M | -$254.4K | 1 | 2019-03-22 |
| REPL | 10%+ Owner | 4,453,386 | $19.39 | $86.35M | $0 | 1 | 2018-07-26 |
Holdings By Holder
| Symbol | Holder | Shares | Share of Total | Reported |
|---|---|---|---|---|
| KYMR | Direct | 4,676,075 | 84.9% | 2024-03-13 |
| Atlas Venture Opportunity Fund I, L.P. See footnote |
828,830 | 15.1% | 2024-03-13 | |
| Total | 5,504,905 | |||
| IRON | Direct | 1,479,686 | 64.7% | 2023-12-14 |
| Atlas Venture Opportunity Fund I, L.P. See footnote |
806,160 | 35.3% | 2023-12-14 | |
| Total | 2,285,846 | |||
| GBIO | Direct | 0 | 0.0% | 2021-04-14 |
| Atlas Venture Fund X, L.P. See footnote |
911,194 | 100.0% | 2021-04-14 | |
| Total | 911,194 | |||
| MGTA | Direct | 257,320 | 99.7% | 2019-03-22 |
| AVA X LP See Footnote |
890 | 0.3% | 2019-03-22 | |
| Total | 258,210 |
Recent Filings
12 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-03-13 | KYMR | Sell (S)10b5-1 Plan adopted Jan 22, 2024 |
−353,357 | -$14.91M | EDGAR |
| 2023-12-14 | IRON | Sell (S) | −190,163 | -$11.68M | EDGAR |
| 2023-08-16 | IRON | Sell (S) | −359,000 | -$18.85M | EDGAR |
| 2022-11-04 | KYMR | Sell (S) | −220,016 | -$6.60M | EDGAR |
| 2021-08-12 | KYMR | Sell (S) | −242,133 | -$14.77M | EDGAR |
| 2021-04-14 | Generation Bio Co. (GBIO) Delisted | Sell (S) | −140,682 | -$3.65M | EDGAR |
| 2021-04-09 | Generation Bio Co. (GBIO) Delisted | Sell (S) | −127,095 | -$3.58M | EDGAR |
| 2021-03-16 | KYMR | Sell (S) | −229,350 | -$12.96M | EDGAR |
| 2020-08-25 | KYMR | Conv (C) | +8,309,270 | $0 | EDGAR |
| 2020-02-18 | Tectonic Therapeutic, Inc. (AVRO) Delisted | Other (J) | −1,046,426 | $0 | EDGAR |
10b5-1: the filer ticked the box for trades made under a Rule 10b5-1 trading plan, which sets the sales (or buys) in advance, so they say less about the insider's view at the time than a discretionary trade. The plan's adoption date is shown when the filing's footnotes give it.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment, and an amended or cancelled notice is not listed. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes. Someone who is no longer an officer or director (or never was) files no Form 4, so for them a sale shows up only on a later notice, which lists the seller's sales from the 3 months before it. "No sale on file" means neither record shows one; a dash in Net $ means the value filed on the notice doesn't fit the stock's price (likely a typo).